IL115125A0 - Pharmaceutical formulations comprising derivatives of clavulanic acid - Google Patents

Pharmaceutical formulations comprising derivatives of clavulanic acid

Info

Publication number
IL115125A0
IL115125A0 IL11512595A IL11512595A IL115125A0 IL 115125 A0 IL115125 A0 IL 115125A0 IL 11512595 A IL11512595 A IL 11512595A IL 11512595 A IL11512595 A IL 11512595A IL 115125 A0 IL115125 A0 IL 115125A0
Authority
IL
Israel
Prior art keywords
derivatives
pharmaceutical formulations
clavulanic acid
clavulanic
acid
Prior art date
Application number
IL11512595A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9417953A external-priority patent/GB9417953D0/en
Priority claimed from GBGB9503752.9A external-priority patent/GB9503752D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL115125A0 publication Critical patent/IL115125A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL11512595A 1994-09-03 1995-09-01 Pharmaceutical formulations comprising derivatives of clavulanic acid IL115125A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9417953A GB9417953D0 (en) 1994-09-03 1994-09-03 Pharmaceutical formulations
GBGB9503752.9A GB9503752D0 (en) 1995-02-24 1995-02-24 Pharmaceutical formulations
US46044195A 1995-06-02 1995-06-02

Publications (1)

Publication Number Publication Date
IL115125A0 true IL115125A0 (en) 1995-12-31

Family

ID=27267365

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11512595A IL115125A0 (en) 1994-09-03 1995-09-01 Pharmaceutical formulations comprising derivatives of clavulanic acid

Country Status (8)

Country Link
EP (1) EP0782443A1 (xx)
JP (1) JPH10505595A (xx)
AU (1) AU3471995A (xx)
DZ (1) DZ1926A1 (xx)
IL (1) IL115125A0 (xx)
MA (1) MA23663A1 (xx)
TR (1) TR199501082A2 (xx)
WO (1) WO1996007408A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997009042A1 (en) 1995-09-07 1997-03-13 Smithkline Beecham Corporation Pharmaceutical formulation
PL334976A1 (en) * 1997-02-14 2000-03-27 Smithkline Beecham Lab Pharmaceutic preparations containing amoxycyclin and clavulate
DE69922202T2 (de) * 1998-07-06 2005-12-01 Nanobac Oy Verfahren zur beseitigung von nanobakterien
US6706290B1 (en) 1998-07-06 2004-03-16 Olvai E. Kajander Methods for eradication of nanobacteria
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US8614315B2 (en) * 2009-12-25 2013-12-24 Mahmut Bilgic Cefdinir and cefixime formulations and uses thereof
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
EP2575781A1 (en) * 2010-06-03 2013-04-10 Mahmut Bilgic Production method for the effervescent formulation comprising cephalosporin and potassium clavulanate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002312B1 (en) * 1977-11-26 1982-02-03 Beecham Group Plc Derivatives of clavulanic acid and pharmaceutical compositions containing them
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
EP0680322B1 (en) * 1993-01-22 2000-07-05 Smithkline Beecham Plc Use of clavulanate and an antibacterial compound for the treatment of infections

Also Published As

Publication number Publication date
EP0782443A1 (en) 1997-07-09
AU3471995A (en) 1996-03-27
TR199501082A2 (tr) 1996-06-21
DZ1926A1 (fr) 2002-02-17
WO1996007408A1 (en) 1996-03-14
JPH10505595A (ja) 1998-06-02
MA23663A1 (fr) 1996-04-01

Similar Documents

Publication Publication Date Title
IL113433A0 (en) Tablet formulations comprising amoxycillin and salts of clavulanic acid
IL117265A (en) Benzazepine- benzoxazepine- and benzothiazepine-N-acetic acid derivatives their preparation and pharmaceutical compositions containing them
EG24044A (en) pharmaceutical formulation of omeprazole
IL117193A0 (en) Poly-pyrrolecarbox-amidenaphthalenic acid derivatives their preparation and pharmaceutical compositions containing them
HUP0100178A3 (en) Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof
IL128600A0 (en) Propionic acid derivatives and pharmaceutical compositions containing them
IL131201A (en) Pharmaceutical formulations comprising amoxycillin and clavulanate
IL105966A0 (en) Preparation of clavulanic acid
HU9502520D0 (en) Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives
IL126271A0 (en) 2-Arylpyrazolisoquinoline and cinnolinone derivatives methods for their preparation and pharmaceutical formulations containing them
PL332249A1 (en) Pharmaceutical microspheres of varproinic acid for oral administration
AU2111095A (en) Salts of omega-3-polyunsaturated fatty acids and pharmaceutical formulations containing them
IL115125A0 (en) Pharmaceutical formulations comprising derivatives of clavulanic acid
AU1847695A (en) Pharmaceutical formulations of cntf
AU8015398A (en) Pharmaceutical formulations containing colostrum and the use of colostrum for the treatment of affections of the oral cavity
IL127691A0 (en) Useful formulations of acid addition salt drugs
AU3363193A (en) Pharmaceutical formulations comprising a clavulanic acid salt and erithromycin derivative
AU5560694A (en) Pharmaceutical formulations of ibuprofen
GB9304745D0 (en) Use of pharmaceutical formulations
GB9525828D0 (en) Use of hetarylacetic acid derivatives
PL328170A1 (en) Ester-type derivatives of transapovincaminic acid as drugs
AU4596097A (en) Improved therapeutic uses of 4-quinoline-carboxylic acid derivatives
GB9226357D0 (en) Preparation of phenyloxoacetic acid derivatives
HUP9903695A3 (en) Oxazolyl- and pyridylethoxyphenyl propionic acid derivatives and pharmaceutical compositions containing them
IL113757A0 (en) Preparation of clavulanic acid